Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

COMy Virtual 2020 | Maximizing supportive care

Heinz Ludwig • 12 May 2020
COMy Virtual 2020
Multiple Myeloma

Heinz Ludwig, MD, Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria, discusses the importance of supportive care when managing multiple myeloma and how it can be maximized. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Heinz Ludwig

Identifying high-risk multiple myeloma & improving treatment strategies in this patient population
Heinz Ludwig et al. • 15 Sep 2022
Factors affecting renal response in myeloma with acute renal failure due to cast nephropathy 5:06
Factors affecting renal response in myeloma with acute renal failure due to cast nephropathy
Heinz Ludwig • 20 Nov 2024
The changing approach to infection management with the influx of novel immunotherapies in myeloma 5:44
The changing approach to infection management with the influx of novel immunotherapies in myeloma
Heinz Ludwig • 20 Nov 2024
The complexities of selecting patients with smoldering myeloma for therapeutic intervention 4:35
The complexities of selecting patients with smoldering myeloma for therapeutic intervention
Heinz Ludwig • 20 Nov 2024

Related Videos

Belantamab mafodotin in functional high-risk RRMM: subgroup analysis of DREAMM-7 and DREAMM-8 4:02
Belantamab mafodotin in functional high-risk RRMM: subgroup analysis of DREAMM-7 and DREAMM-8
Meral Beksac • 10 Dec 2025
Incidence and risk factors for infections in NDMM treated with modern induction regimens 1:54
Incidence and risk factors for infections in NDMM treated with modern induction regimens
Efstathios Kastritis • 7 Dec 2025
A real-world analysis of infections in patients with RRMM receiving ide-cel 3:59
A real-world analysis of infections in patients with RRMM receiving ide-cel
Muhammad Bilal Abid • 6 Dec 2025
Integrating molecular diagnostics in smoldering myeloma to predict disease progression 1:37
Integrating molecular diagnostics in smoldering myeloma to predict disease progression
Gareth Morgan • 7 Dec 2025
The content of VJHemOnc is intended for healthcare professionals